Boston Scientific (NYSE:BSX) announced today that it has initiated a global, voluntary recall of its Lotus Edge aortic valve system — and is immediately retiring the Lotus program. Marlborough, Mass.-based Boston Scientific said in a news release that the recall of all unused inventory of its Lotus Edge transcatheter aortic valve repair (TAVR) system is due […]
Edwards Lifesciences
DTW Podcast: Hear the future of AI, 3D, and Dx from Edwards, Stryker, Evercore, Checkable
In this week’s episode of DeviceTalks Weekly we review the Medical Design & Outsourcing’s Women in Medtech issue — bringing you insights through interviews with Katie Syzman, corporate VP and the GM of critical care at Edwards Lifesciences, Naomi Murray, Stryker’s director of advanced operations, and Patty Post, CEO of Startup Checkable Medical. Szyman […]
Edwards reports better-than-expected Q3 results
Edwards Lifesciences (NYSE:EW) shares hardly moved after hours on third-quarter results that came in ahead of the consensus forecast. The Irvine, Calif.-based company posted profits of $325.2 million, or 52¢ per share, on sales of $1.14 billion for the three months ended Sept. 30, 2020, for an 18.4% bottom-line gain on sales growth of 4.3%. Adjusted […]
Abbott beats the Street in Q3, projects higher full-year sales
Abbott (NYSE:ABT) posted stronger-than-expected third-quarter earnings today and upped its full-year projections. The Abbott Park, Ill.-based healthcare giant reported profits of $1.232 billion or 98¢ per share for the quarter ended Sept. 30, 2020, led by a whopping 38.2% increase in global diagnostics sales and a 27% sales jump for diabetes care devices. Analysts had projected […]
The top 5 MassDevice stories of the week — October 16, 2020
For the second consecutive week, medtech giant Medtronic (NYSE:MDT) managed to dominate the news on MassDevice. The company’s “Investor Day” brought about several headlines, including new clinical trials ahead and a rallying cry from CEO Geoff Martha. Other news that garnered some attention came in the form of a new ultrasound system from another big player […]
Medtronic CEO Geoff Martha: ‘Time to be bold and add grit’
Medtronic (NYSE:MDT) CEO Geoff Martha has no intention of slowing the medtech giant down amid the COVID-19 pandemic. Speaking during the Fridley, Minn.-based company’s “Investor Day” virtual presentation, Martha made one thing clear: “We are going on the offensive,” Martha said at the start and echoed throughout the program. About six months into his tenure as […]
Medtronic launches head-to-head TAVR study against Edwards
Medtronic (NYSE:MDT) today announced it will begin a randomized, head-to-head study comparing two transcatheter aortic valve replacement (TAVR) systems in patients with severe symptomatic aortic stenosis (ssAS), primarily in women. The postmarket SMART trial will compare valve safety and performance of the self-expanding Medtronic Evolut PRO and PRO+TAVR Systems against Edwards Lifesciences’ (NYSE:EW) balloon-expandable SAPIEN 3 and […]
MedTech 100 roundup: New peak for industry
Stocks in the medtech industry continue to impress as, over the past week, they set a new benchmark amid the COVID-19 pandemic. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 95.05 (Oct. 9), marking a 5.9% gain from the 89.73 points registered at the […]
AI could boost Edwards’ critical care business
Critical care comprises nearly 20% of Edwards’ revenue. Its continued growth is connected to the prominence of the company’s heart valve business. Katie Szyman spent 23 years at Medtronic, a giant in the Medtech industry, but a patient-focused outlook became a driving force behind a change for her. Wanting to work for a California-based company […]
Moody’s sees higher earnings, increased demand for medical device companies
Moody’s Investors Service announced today that it is changing its outlook for the medical device industry to positive — up from stable. The COVID-19 pandemic previously caused a suspension of non-urgent medical care, but procedure numbers have bounced back, said Moody’s, which expects the positive trend to continue as a result of pent-up demand and […]
Which TAVR device is the best? It depends, researchers say
Researchers published a paper in the Journal of the American Medical Association citing insufficient evidence regarding the superiority of TAVR devices. Currently, only three TAVR devices are commercially available in the U.S., belonging to Edwards Lifesciences (NYSE:EW), Medtronic (NYSE:MDT) and Boston Scientific (NYSE:BSX), although several others are being used in clinical trials to evaluate safety and efficacy. Get the full story at our […]
